NCT02993198View on ClinicalTrials.gov

A Prospective Study of Breast Cancer Patients With Abnormal Strain Imaging

PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

134

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

HER2 Positive Breast CancerCardiovascular Abnormalities

Interventions

DRUG

Carvedilol

Trial Locations (1)

60611

Northwestern University, Chicago

All Listed Sponsors

lead

Northwestern University

OTHER